Results

Total Results: 1,494 records

Showing results for "harms".

  1. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
    December 01, 2011 - (b) What are the harms associated with prevention strategies? … What are the effectiveness and harms of nonstandard adjunctive interventions? … No data on patient harms or harms to hospital staff due to preventive interventions were reported. … • Harms were not reported. … • Harms were not reported.
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_research-protocol.pdf
    January 01, 2020 - What are the potential safety issues and harms of vibration therapy when used to treat osteoporosis? … What primary and secondary outcomes and harms were examined? e. … What comparators were used to examine benefits and harms? f. … What was the length of followup to examine benefits and harms? g. … What are the possible areas of confusion or potential harms from misuse in direct-to-consumer marketing
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
    March 01, 2019 - None of the trials were powered to evaluate harms as they were all designed to assess efficacy. … Important research gaps must be addressed to understand more fully the harms associated with antidepressant … We found no evidence to assess harms for several therapies of interest including fluvoxamine, 11 … Overall, additional research is needed to characterize important harms associated with therapies used … depression in older adults: Research protocol. https:// effectivehealthcare.ahrq.gov/topics/depression-harms
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
    April 01, 2022 - This report addressed benefits and harms of nonopioid pharmacologic treatments in adults with chronic … All the studies addressed benefits and five addressed harms. … No change in conclusions Harms KQ2. … Tricyclic Antidepressants Two new RCTs reported harms associated with TCAs versus placebo. … Harms and Adverse Events a.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_executive.pdf
    January 01, 2010 - A comprehensive review evaluating the benefits and harms of screening for MRSA carriage will identify … Morbidity, Mortality, Harms, and Resource Utilization Because no studies addressed these outcomes, the … Morbidity, Mortality, Harms, and Resource Utilization Because no studies addressed these outcomes, the … Morbidity, Mortality, Harms, and Resource Utilization Because no studies addressed these outcomes, the … Morbidity, Mortality, Harms, and Resource Utilization Because no studies addressed these outcomes, the
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/labor-nitrous-oxide_executive.pdf
    August 01, 2012 - One-third (16 of 49) of studies reporting harms were conducted prior to 1980, when nitrous oxide was … Studies reporting harms associated with sedative analgesic regimens may not translate effectively to … Most maternal harms reported in the literature were unpleasant side effects that affect tolerability … Study sizes were inadequate to assess for unusual or rare harms that might be more serious. … Data for occupational harms were limited.
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
    November 19, 2012 - standard set of tests or consensus regarding whether testing improves treatment outcomes or induces harms … may affect treatment decisions.4 However, there is no consensus regarding the relative benefits and harms … KQ2: What are the harms and comparative harms of treatments for chronic urinary retention in adults: … KQ2: What are the harms and comparative harms of treatments for chronic urinary retention in adults: … KQ2a: What patient or condition characteristics (e.g., age, severity, etc.) modify the harms of treatment
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-treatment_research-protocol.pdf
    November 08, 2011 - Our review will include an assessment of adverse effects or harms associated with pressure ulcer treatment … Question 2 What are the harms of treatments for pressure ulcers? … Question 2a Do the harms of treatment strategies differ according to features of the pressure ulcers … Question 2b Do the harms of treatment strategies differ according to patient characteristics, including … Question 2c Do the harms of treatment strategies differ according to patient care settings such as
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bereaved-persons-research-executive-summ.pdf
    March 01, 2025 - What are the effectiveness and harms of universal screening for bereavement and response to loss? … What are the effectiveness, comparative effectiveness, and harms of interventions for people at risk … What are the effectiveness, comparative effectiveness, and harms of interventions for people diagnosed … symptoms, more evidence is needed to quantify the presence and absence of unintended consequences, harms
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_executive.pdf
    March 01, 2013 - studies that do report on harms data were excluded. … Harms associated with tube feeding include surgical harms, infection, increased rates of reflux requiring … One prospective cohort study focused primarily on harms. … Considerable uncertainty remains concerning harms over both the short and long term. … Considerable uncertainty remains concerning harms over both the short and long term.
  11. effectivehealthcare.ahrq.gov/products/deprescribing-mhs4/protocol
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_executive.pdf
    April 01, 2013 - What are the comparative benefits and harms of erythropoiesis-stimulating agent strategies and non-ESA … alternative thresholds for initiating treatment compare regarding their effect on the benefits and harms … discontinuing therapy or for optimal duration of therapy compare regarding their effect on the benefits and harms … It is unknown whether dosing practices and overall ESA exposure influence harms.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
    May 01, 2022 - No adverse events were reported in the NSAID arm; other harms were not reported. … Harms were not reported. … harms, infections, cardiovascular events, cognitive harms, and psychological harms (e.g., depression … harms, cardiovascular- B-3 related harms, kidney-related harms, falls, fractures, motor vehicle … accidents, endocrinological harms, infections, cognitive harms, and psychological harms (e.g., depression
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
    November 03, 2011 - What are the harms from preventive pharmacologic treatments when compared to active treatments? …  Harms: o All reported adverse reactions and effects (such as anxiety, nausea, vomiting, sleep … Timing  6 months or more; optimally 12 months  Any time of occurrence for the harms Setting … of drugs in patients with migraine. 48 The EPC will define harms as a totality of all possible … adverse consequences of an intervention. 48 The EPC will analyze harms regardless of how authors
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
    September 01, 2009 - Combining different types of medications may appear attractive but could result in more harms, be less … Compared with higher dose statins and to one another, do combination regimens differ in benefits and harmsHarms were SAE, cancer, treatment adherence, withdrawal due to adverse events, participants with at least … • Harms should be prospectively collected and comprehensively reported. … Benefits and Harms Within Subgroups of Patients • Trials should be conducted in, or oversample, specific
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-195-uterine-fibroids-final.pdf
    December 01, 2017 - Clinical trials are not powered to detect harms. … Harms included spotting, elevations in liver function enzymes, and endometrial hyperplasia. … Harms associated with myomectomy included transfusion and pelvic organ injury. … Harms did not differ among techniques. … Seven reported harms only (i.e., did not report final health outcomes for effectiveness).
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
    April 01, 2024 - None of the studies reported rates of unintended harms. Conclusions. … What is the frequency and severity of harms associated with care transitions? 2. … What patient safety measures or indicators have been used to examine these harms? 3. … What Are the Frequency and Severity of Harms Associated With Care Transitions? … There are numerous harms associated with care transitions.
  18. Woolf_ECCS2012 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/woolf_eccs2012.pdf
    January 01, 2012 - context into  account,  including  the  patient's  values   regarding specific benefits and harms … Services  Task Force: Reaction to the 2009 Mammography Controversy (2  of 2) • The potential harms
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
    July 13, 2011 - The report will summarize the available evidence on the comparative efficacy, effectiveness, and harms … KQ5) Maintenance of remission (KQ2, KQ5) Associated symptoms (KQ3, KQ5) Adverse events Harms … this decision is directly impacted by a discussion with the health care provider about benefits and harms … ; key question 4 will rate general efficacy/effectiveness as well as comparative risk for specific harms … ; and key question 5 will also rate comparative harms.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - KQ 1: In adults with normal cognition, what are the effectiveness, comparative effectiveness, and harms … Do effectiveness, comparative effectiveness, and harms of interventions differ as a function of patient … Do effectiveness, comparative effectiveness, and harms of interventions differ as a function of patient … Any harm associated with intervention  (e.g. drug   side  effects, physical harms,  etc.) … For  KQ2:  To  test  the  efficacy,  comparative  effectiveness,  and  harms  of   interventions to  

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: